Exocan Healthcare

India’s first exosome‑focused biotech advancing therapeutic and diagnostic solutions for cancer and regenerative medicine.

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

India’s first exosome‑focused biotech advancing therapeutic and diagnostic solutions for cancer and regenerative medicine.

OncologyRegenerative Medicine

ExoCan leverages a patented exosome discovery platform to engineer exosomes for targeted cargo delivery and liquid‑biopsy diagnostics in cancer.

Exosome‑based therapeutics and diagnostics represent a rapidly growing segment with high unmet need in oncology and regenerative medicine.

Technology translation, regulatory pathways for exosome therapeutics, and competition from larger biotech firms pose significant risks.

Few companies have clinically‑stage exosome platforms; ExoCan differentiates through its integrated cargo delivery and liquid‑biopsy capabilities.